Sagar Lonial, MD, FACP, on Multiple Myeloma Awareness Month

Sagar Lonial, MD, FACP, on Multiple Myeloma Awareness Month

IMS Highlights for Triple Class Refractory Myeloma | Sagar Lonial, MD, FACP | IMS 2023Подробнее

IMS Highlights for Triple Class Refractory Myeloma | Sagar Lonial, MD, FACP | IMS 2023

Sagar Lonial, MD, FACP, Talks Multiple Myeloma Highlights from the Summer ConferencesПодробнее

Sagar Lonial, MD, FACP, Talks Multiple Myeloma Highlights from the Summer Conferences

Dr. Lonial on Treating Early Relapse in Multiple MyelomaПодробнее

Dr. Lonial on Treating Early Relapse in Multiple Myeloma

Iberdomide with dexamethasone for R/R multiple myelomaПодробнее

Iberdomide with dexamethasone for R/R multiple myeloma

The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in MyelomaПодробнее

The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in Myeloma

DARA + pom-dex for R/R multiple myelomaПодробнее

DARA + pom-dex for R/R multiple myeloma

Sagar Lonial MD, FACP, discusses unmet need for multiple myeloma patientsПодробнее

Sagar Lonial MD, FACP, discusses unmet need for multiple myeloma patients

Sagar Lonial MD, FACP, on predicting venetoclax sensitivity in MM using biologic active assaysПодробнее

Sagar Lonial MD, FACP, on predicting venetoclax sensitivity in MM using biologic active assays

Carfilzomib and panobinostat for R/R multiple myeloma: Phase I resultsПодробнее

Carfilzomib and panobinostat for R/R multiple myeloma: Phase I results

Sagar Lonial discusses his top myeloma research picksПодробнее

Sagar Lonial discusses his top myeloma research picks